Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C for UTI Prevention in GYN Surgery
NCT03800667Phase 1Withdrawn
- Sponsor
- American University of Beirut Medical Center
- Start
- Aug 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ascorbic acid in catheter-associated urinary tract infection (CAUTI) (2 arms), sponsored by American University of Beirut Medical Center. Primary endpoint: Proportion of participants who experienced clinically diagnosed and treated UTI at 30 days. Planned start Aug 2018; status: withdrawn.
02
Drugs
ascorbic acid
03
Conditions
catheter-associated urinary tract infection (CAUTI)
Beyond the preview
Go deeper on NCT03800667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03800667.